Skip to main content

Table 1 Patient characteristics (n = 219)

From: Pretreatment prognostic factors of survival and late toxicities for patients with nasopharyngeal carcinoma treated by simultaneous integrated boost intensity-modulated radiotherapy

Variable

Number

Percent

Age, range (median)

15–87 (52)

 

  ≤ 50 year

97

44.3

  > 50 year

122

55.7

Gender

 Male

161

73.5

 Female

58

26.5

Educational level

  ≤ 12 year

165

75.3

  > 12 year

54

24.7

Marital status

 With spouse

160

73.1

 Without spouse

59

26.9

Smoking history

 Yes

92

42.0

 No

127

58.0

Charlson comorbidity index

 0

125

57.1

  ≥ 1

94

42.9

Body mass index

  < 23

62

28.8

  ≥ 23

157

71.2

WHO histology

 Type I

3

1.4

 Type IIA

98

44.7

 Type IIB

118

53.9

Clinical stagea

 I

27

12.3

 II

45

20.6

 III

67

30.6

 IVA-B

80

36.5

T classificationa

 T1

98

44.7

 T2

35

16.0

 T3

48

21.9

 T4

38

17.4

N classificationa

 N0

37

16.9

 N1

72

32.9

 N2

64

29.2

 N3

46

21.0

Chemotherapy

 Concurrent chemotherapy

192

87.7

 Adjuvant chemotherapy

144

65.8

  1. WHO World Health Organization
  2. aAccording to the AJCC 7th staging system